Yar Saglam, A. S. (2016) “HDAC inhibitors, MS-275 and salermide, potentiates the anticancer effect of EF24 in human pancreatic cancer cells”, EXCLI Journal, 15, pp. 246–255. doi: 10.17179/excli2016-186.